Literature DB >> 23843097

Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.

Amanda C Wieland1, Matthew Quallick, Aimee Truesdale, Pamela Mettler, Kiran M Bambha.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. Primary care providers (PCPs), in contrast to gastroenterology/hepatology (GI/Hep) providers, are the first medical contact for the majority of patients with, or at risk for, NAFLD. PCP awareness of and facility with NAFLD is critical for management of these patients. AIM: The purpose of this study was to assess understanding and practice patterns of PCPs and non-GI/Hep subspecialty providers with respect to the diagnosis and management of NAFLD.
METHODS: We administered an online, 61-question survey to 479 providers in internal medicine, family medicine, endocrinology, cardiology, and obstetrics and gynecology (ObGyn) across three health systems: academic medical center, safety-net health system and managed care health system.
RESULTS: There were 246 respondents (51 %), with the majority (87 %) being PCPs (internal medicine, family medicine, ObGyn). Only 31 % of providers identified NAFLD as a clinically important diagnosis in their practice. Although 65 % of providers reported some degree of facility in diagnosing NAFLD, less than half (47 %) were comfortable managing NAFLD. Only 33 % refer patients with suspected NAFLD to GI/Hep. Subspecialists in endocrinology and cardiology reported greater clinical concern over NAFLD and were more likely (67 %) to refer patients with suspected NAFLD to GI/Hep.
CONCLUSIONS: The majority of providers do not identify NAFLD as a clinically important diagnosis and do not refer to GI/Hep. However, 83 % expressed a need for education on NAFLD. Our data reveal practice gaps within NAFLD care and identify opportunities for targeted education to guide PCPs in the evaluation and management of NAFLD.

Entities:  

Mesh:

Year:  2013        PMID: 23843097     DOI: 10.1007/s10620-013-2740-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.

Authors:  C-J Bergqvist; R Skoien; L Horsfall; A D Clouston; J R Jonsson; E E Powell
Journal:  Intern Med J       Date:  2013-03       Impact factor: 2.048

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Upper limits of normal for alanine aminotransferase activity in the United States population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

4.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 5.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

Review 6.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

7.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

8.  Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program.

Authors:  Ignazio Grattagliano; Gaetano D'Ambrosio; Gaetano D'Ambrozio; Vincenzo O Palmieri; Antonio Moschetta; Giuseppe Palasciano; Piero Portincasa
Journal:  J Gastrointestin Liver Dis       Date:  2008-12       Impact factor: 2.008

9.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

Review 10.  Epidemiology and natural history of NAFLD and NASH.

Authors:  Janus P Ong; Zobair M Younossi
Journal:  Clin Liver Dis       Date:  2007-02       Impact factor: 6.126

View more
  12 in total

Review 1.  Defining comprehensive models of care for NAFLD.

Authors:  Manuel Romero-Gómez; Jörn M Schattenberg; Jeffrey V Lazarus; Quentin M Anstee; Hannes Hagström; Kenneth Cusi; Helena Cortez-Pinto; Henry E Mark; Michael Roden; Emmanuel A Tsochatzis; Vincent Wai-Sun Wong; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-25       Impact factor: 46.802

2.  Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.

Authors:  Victoria Lee-Kim; Rachael Morkem; David Barber; Jennifer A Flemming; Mohit Kehar
Journal:  Paediatr Child Health       Date:  2021-08-27       Impact factor: 2.600

Review 3.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

4.  Nonalcoholic fatty liver disease is underrecognized in the primary care setting.

Authors:  Pierre Blais; Nisreen Husain; Jennifer R Kramer; Marc Kowalkowski; Hashem El-Serag; Fasiha Kanwal
Journal:  Am J Gastroenterol       Date:  2014-06-03       Impact factor: 10.864

5.  Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico.

Authors:  Paulina Vidal-Cevallos; Ana L Ordóñez-Vázquez; Omar Procopio-Mosso; Rafael Cardoso-Arias; Misael Uribe; Norberto C Chávez-Tapia
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

6.  Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.

Authors:  Susan Polanco-Briceno; Daniel Glass; Mark Stuntz; Alexis Caze
Journal:  BMC Res Notes       Date:  2016-03-11

7.  Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma.

Authors:  Luis C Bertot; Gary P Jeffrey; Michael Wallace; Gerry MacQuillan; George Garas; Helena L Ching; Leon A Adams
Journal:  Hepatol Commun       Date:  2017-02-27

8.  Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?

Authors:  Arun J Sanyal
Journal:  BMC Med       Date:  2018-08-24       Impact factor: 8.775

9.  Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs.

Authors:  Adam E Mikolajczyk; Netanel Zilberstein; John F McConville; Alex Pan; Andrew I Aronsohn; Helen S Te; Gautham Reddy; Sonali Paul; Anjana Pillai; Michael Charlton; Jeanne M Farnan
Journal:  Hepatol Commun       Date:  2021-07-28

10.  NASH-RELATED CIRRHOSIS: AN OCCULT LIVER DISEASE BURDEN.

Authors:  Marco Arrese; Ariel E Feldstein
Journal:  Hepatol Commun       Date:  2017-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.